Answers are grounded in this paper and cite their sources.
Developing potent adjuvants for the stimulation of robust immune response is central for effective cancer immunotherapy. Double‐shelled dendritic mesoporous organosilica hollow spheres are an excellent adjuvant and provide superior immunity in cancer immunotherapy, and better than their counterparts either with a pure silica composition or a single‐walled architecture. This study provides new insights in the rational design of effective nanostructured adjuvants for vaccine developments.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: